BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.21B
AUM Growth
-$804M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
166
New
Increased
Reduced
Closed

Top Buys

1 +$31.1M
2 +$24.2M
3 +$21.5M
4
HUM icon
Humana
HUM
+$20.8M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$10.5M

Top Sells

1 +$60.3M
2 +$56.9M
3 +$32.8M
4
CRL icon
Charles River Laboratories
CRL
+$16.7M
5
TMO icon
Thermo Fisher Scientific
TMO
+$15M

Sector Composition

1 Healthcare 99.13%
2 Industrials 0.77%
3 Energy 0.04%
4 Communication Services 0.01%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
101
$4.67M 0.08%
22,000
102
$4.45M 0.07%
17,314
-8,284
103
$4.12M 0.07%
4,204,264
-4,000
104
$3.81M 0.06%
198,171
-20,402
105
$3.55M 0.06%
22,823
+1,598
106
$3.2M 0.05%
217,256
-22,368
107
$3.08M 0.05%
17,087
+1,177
108
$2.47M 0.04%
35,314
109
$2.36M 0.04%
5,425
+2,129
110
$2.32M 0.04%
284,000
-34,300
111
$2.29M 0.04%
81,700
112
$2.21M 0.04%
74,525
-7,672
113
$2.08M 0.03%
78,700
-18,200
114
$1.74M 0.03%
+176,848
115
$1.68M 0.03%
+73,300
116
$1.55M 0.03%
30,500
+4,500
117
$1.45M 0.02%
12,500
-5,500
118
$1.4M 0.02%
6,988
-1,146
119
$1.33M 0.02%
+91,606
120
$1.33M 0.02%
+174,085
121
$1.26M 0.02%
25,000
-2,100
122
$1.23M 0.02%
+83,200
123
$1.17M 0.02%
6,900
-3,200
124
$1.12M 0.02%
6,462
-34
125
$1.11M 0.02%
2,600
+800